Your destination for the latest TriviumVet news and announcements.

RAPACAT HCM trial results unveiled at International Cardio-Renal Veterinary Symposium (ICVS) 2022
Dr. Josh Stern to present the positive findings of RAPACAT HCM Clinical Trial this Sunday 02nd October at ICVS 2022
TriviumVet to exhibit at VMX 2023. TriviumVet will be participating in the New Exhibitors Area – Zone A – Booth 5203
The annual conference will be held 14 to 18 January in person in Orlando, Florida, at the Orange County Convention Center
A great summary by FDA's Dr. Christopher Loss on Conditionally Approved Animal Drugs and what it means to use them
The purpose of this article is to provide veterinarians with an understanding of what it means to use a conditionally approved drug.
Esteemed veterinary cardiologist and researcher Dr. Joshua Stern appointed to the TriviumVet Scientific Advisory Board
Esteemed veterinary cardiologist and researcher Dr. Joshua Stern appointed to the TriviumVet Scientific Advisory Board.
TriviumVet work with The Ohio State University evaluating the benefit of Rapamycin in cats.
We are delighted to be working with The Ohio State University on an exciting clinical trial
TriviumVet support UC Davis and the Morris Animal Foundation in a novel research.
We are excited to support UC Davis and the Morris Animal Foundation in a novel research. Subvalvular aortic stenosis (SAS)
A great catch up with our colleagues in the US.
Our CTO Stuart Fitzgerald and Regulatory Affairs Manager Susan Kennedy had a successful trip to the US
CEO Louise Grubb won Entrepreneur of The Year at the 2021 Waterford Business Awards.
A great celebration for our female led company as our CEO Louise Grubb has won Entrepreneur of The Year
TriviumVet represented at the VMX Conference presented by North American Veterinary Community
It was great to have TriviumVet represented by our CEO Louise Grubb and CTO Stuart Fitzgerald at a very informative VMX conference